SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is currently experiencing intense volatility and downward pressure as traders debate whether the stock is undergoing a long-overdue correction following a rapid price surge or a deliberate institutional-led unwind. The community is actively tracking frequent trading halts and divided between those attempting to catch a reversal bounce and others anticipating a return to historical price levels due to underlying fundamental concerns.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is experiencing significant volatility and trading volume as investors react to the latest quarterly update, which highlighted progress on the Eagle Line production ramp and new commercial engagements in the AI data center and defense sectors. The stock has become a focal point for intense debate between market participants debating whether these operational milestones signal a long-term turnaround or if the current price action remains driven by speculative short-term trading and potential dilution concerns.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending as investors closely monitor potential data center capacity deals and upcoming energization milestones, while the stock faces significant volatility from market makers and ongoing debates over share dilution. Community sentiment remains polarized between long-term bulls betting on the company's power-secured infrastructure moat and skeptics concerned about management's communication and frequent price reversals.

Applied Digital Corporation

Applied Digital is trending as investors rally behind a new 7.5 billion dollar AI data center lease with a major hyperscaler, significantly expanding the company's contracted revenue backlog. The community is actively debating the potential identity of this new partner, the impact of high short interest on future price action, and the company's long-term growth trajectory within the AI infrastructure sector.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Investors in this leveraged inverse semiconductor ETF are expressing significant frustration as an unprecedented, multi-week rally in the chip sector continues to erode value and trigger persistent daily losses. The community is actively debating whether this extreme market behavior indicates a bubble fueled by algorithmic manipulation or a genuine, long-term super-cycle in AI-driven demand.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is experiencing a parabolic, historic rally driven by intense speculative demand in the semiconductor sector and significant short covering, leading to a heated community debate over whether this represents an unsustainable 'AI bubble' or a new era of market growth. While many bulls are celebrating massive double-digit gains and calling for further upside, bears are warning of an imminent, sharp correction, causing friction and active trading in both the bull and bear leveraged ETFs.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon shares are facing intense volatility driven by market skepticism over the appointment of a former Nike executive as the company's new CEO and broader concerns regarding brand saturation and competitive pressure. While some investors view the current low valuation as a potential entry point for long-term recovery, the community remains deeply divided, with many actively debating whether the leadership change signals a strategic turnaround or continued brand decline.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is currently trending due to a surge in market optimism surrounding U.S. federal cannabis rescheduling, which the community sees as a long-awaited catalyst for tax relief and improved banking access. Investors are actively debating the sustainability of this momentum, weighing potential short squeezes and institutional interest against historical patterns of profit-taking and reflexive market volatility.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

The iShares Semiconductor ETF (SOXX) is currently experiencing extreme volatility as market participants debate whether the recent aggressive rally is a sustainable trend or a blow-off top fueled by AI exuberance. While some traders are aggressively adding to leveraged short positions, anticipating a technical correction, others remain focused on the potential for continued momentum as the sector remains the primary leader in an AI-concentrated market.

Trio-Tech International engages in the provision of third-party semiconductor testing and burn-in services. It operates through the following segments: Semiconductor Back-End Solutions (SBS) and Industrial Electronics. The SBS segment is focused on the sale of burn-in and reliability test equipment used in the back-end manufacturing processes of semiconductors. Its equipment includes burn-in systems, burn-in boards, and related equipment that is used in the testing of structural integrity of integrated circuits. The Industrial Electronics segment consists of designing, manufacturing, and distributing a range of tests, processes, and other equipment used in the manufacturing processes of customers in various industries in the consumer and industrial market. The company was founded in 1958 and is headquartered in Los Angeles, CA.

Trio-Tech International

Trio-Tech International is currently trending as a high-growth, low-valuation play within the AI and semiconductor testing sector, with the community actively discussing its recent orders for AI GPU burn-in boards and potential for a valuation re-rating. Investors are monitoring the stock's momentum, volume structure, and potential for fundamental growth to continue amid ongoing price discovery.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Amneal (AMRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Amneal (AMRX) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

AMRX Announces Kashiv BioSciences Buyout, Solid Q1 Preliminary Results

Amneal's deal to buy Kashiv for up to $1.10B aids biosimilar push. The company posts strong preliminary Q1 results and raises 2026 EPS guidance.

Amneal Pharmaceuticals (NASDAQ:AMRX) Issues Earnings Results

Amneal Pharmaceuticals (NASDAQ:AMRX - Get Free Report) released its earnings results on Wednesday. The company reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.15 by $0.11. Amneal Pharmaceuticals had a negative return on equity of 228.24% and a net...

Amneal Pharmaceuticals (NASDAQ:AMRX) Updates Q1 2026 Earnings Guidance

Amneal Pharmaceuticals (NASDAQ:AMRX) updated its first quarter 2026 earnings guidance. The company provided EPS guidance of 0.270-0.270 for the period, compared to the consensus estimate of 0.160...

Futures Rise After Trump Extends Ceasefire Even As Brent Tops $100

Amneal Pharmaceuticals (NASDAQ:AMRX) Updates FY 2026 Earnings Guidance

Amneal Pharmaceuticals (NASDAQ:AMRX) updated its FY 2026 earnings guidance. The company provided EPS guidance of 0.950-1.050 for the period, compared to the consensus estimate of 0.950. The company...

Amneal Pharmaceuticals (AMRX) Q1 Earnings and Revenues Surpass Estimates

Amneal (AMRX) delivered earnings and revenue surprises of +63.64% and +1.86%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Why Is Amneal Pharmaceuticals Stock Gaining Today?

Amneal Pharmaceuticals rises premarket after $1.1B Kashiv BioSciences deal to expand biosimilars platform and tap $300B biologics opportunity, while raising FY26 outlook.read more...

Kashiv BioSciences Agrees to Be Acquired by Amneal Pharmaceuticals to Create a Fully Integrated Global Biosimilar Leader

Kashiv BioSciences, LLC (Kashiv), today announced that it has entered into a definitive agreement to be acquired by Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (Amneal). The transaction is subject to...

Amneal Pharmaceuticals (NASDAQ:AMRX) Stock Price Down 5.5% - Time to Sell?

Amneal Pharmaceuticals (NASDAQ:AMRX) Stock Price Down 5.5% - What's Next...

Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog. It operates through the following segments: Generics, Specialty, and AvKARE. The Generics segment relates to oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, and transdermal patches and topicals. The Specialty segment refers to the development, promotion, sale, and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical, and surgical products and services to governmental agencies. The company was founded by Chirag K. Patel and Chintu Patel in 2002 and is headquartered in Bridgewater, NJ.

AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest AMRX News

AMRXAmneal Pharmaceuticals Inc - Ordinary Shares - Class A